Indications and uses
Temporarily relieves these symptoms due to hay fever or other respiratory allergies: runny nose sneezing itchy, watery eyes itching of the nose or throat
Gencare-Allergy Relief Loratadine Tablets, 10 mg
- Manufacturer
- Pioneer Life Sciences, LLC
- Effective date
- 2025-06-30
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-06-01 01:06:14
Label at a glance#
ProductGencare-Allergy Relief Loratadine Tablets, 10 mg
Active ingredientLORATADINE
Label structure14 sections
Dosage and administration
Adults and children 6 years and over: 1 tablet daily; not more than 1 tablet in 24 hours. Children under 6 years of age: Ask a doctor. Consumers with liver or kidney disease: Ask a doctor
Contacts and useful links#
Label contents#
Full prescribing information#
OTC - ACTIVE INGREDIENT SECTION
Active Ingredient (in each tablet)
Loratadine, 10 mg
OTC - PURPOSE SECTION
Purpose
Antihistamine
Uses
Temporarily relieves these symptoms due to hay fever or other respiratory allergies:
- runny nose
- sneezing
- itchy, watery eyes
- itching of the nose or throat
Warnings
Do not use if you ever have had an allergic reaction to this product or any of its ingredients.
OTC - ASK DOCTOR SECTION
Ask a doctor before use if you have liver or kidney disease. Your doctor should determine if you need a different dose.
OTC - WHEN USING SECTION
When using this product do not take more than directed. Taking more than directed may cause drowsiness.
OTC - STOP USE SECTION
Stop use and ask a doctor if an allergic reaction to this product occurs. Seek medical help right away.
OTC - PREGNANCY OR BREAST FEEDING SECTION
If pregnanct or breast-feeding, ask a health professional before use.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children. In case of overdose, get medical help or contact a poison control center right away (1-800-222-1222)
Directions
Adults and children 6 years and over: 1 tablet daily; not more than 1 tablet in 24 hours.
Children under 6 years of age: Ask a doctor.
Consumers with liver or kidney disease: Ask a doctor
Other Information
- Store between 20° to 25°C (68° to 77°F) (see USP Controlled Room Temperature)
- Protect from excessive moisture
Inactive ingredients
Lactose monohydrate, magnesium stearate, povidone, maize starch, purified water.
OTC - QUESTIONS SECTION
Questions or comments?
Call: +1 (732) 994-2808 or email: support@gencare.health
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
DailyMed RxNorm Mappings#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 72090-051-01 | Gencare-Allergy Relief Loratadine Tablets, 10 mg | 300 in 1 BOTTLE | TABLET | 300 | 1 |
Products#
Every source-derived product name is available through these pages.
- Gencare-Allergy Relief Loratadine Tablets, 10 mg
- loratadine
- LACTOSE MONOHYDRATE
- MAGNESIUM STEARATE
- povidone
- STARCH, CORN
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 72090-051 | 72090-051-01 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| LORATADINE | 7AJO3BO7QN | ACTIB |
| LACTOSE MONOHYDRATE | EWQ57Q8I5X | IACT |
| MAGNESIUM STEARATE | 70097M6I30 | IACT |
| povidone | FZ989GH94E | IACT |
| STARCH, CORN | O8232NY3SJ | IACT |
Source Document#
Orange Book application contexts#
All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A214684-001 | LORATADINE | LORATADINE | 10MG | TABLET / ORAL | 2021-01-07 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A214684-001 | LORATADINE | 10MG | TABLET / ORAL | 2021-01-07 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A214684-001 | LORATADINE | 10MG | TABLET / ORAL | 2021-01-07 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A214684-001 | LORATADINE | 10MG | TABLET / ORAL | 2021-01-07 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A214684-001 | LORATADINE | 10MG | TABLET / ORAL | 2021-01-07 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A214684-001 | LORATADINE | 10MG | TABLET / ORAL | 2021-01-07 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A214684-001 | LORATADINE | 10MG | TABLET / ORAL | 2021-01-07 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A214684-001 | LORATADINE | 10MG | TABLET / ORAL | 2021-01-07 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A214684-001 | LORATADINE | 10MG | TABLET / ORAL | 2021-01-07 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A214684-001 | LORATADINE | 10MG | TABLET / ORAL | 2021-01-07 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A214684-001 | LORATADINE | 10MG | TABLET / ORAL | 2021-01-07 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A214684-001 | LORATADINE | 10MG | TABLET / ORAL | 2021-01-07 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A214684-001 | LORATADINE | 10MG | TABLET / ORAL | 2021-01-07 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A214684-001 | LORATADINE | 10MG | TABLET / ORAL | 2021-01-07 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A214684-001 | LORATADINE | 10MG | TABLET / ORAL | 2021-01-07 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A214684-001 | LORATADINE | 10MG | TABLET / ORAL | 2021-01-07 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A214684-001 | LORATADINE | 10MG | TABLET / ORAL | 2021-01-07 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A214684-001 | LORATADINE | 10MG | TABLET / ORAL | 2021-01-07 | 5c6f7cd8ea54… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A214684-001 | LORATADINE | 10MG | TABLET / ORAL | 2021-01-07 | 5d02ea3f76ae… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A214684-001 | LORATADINE | 10MG | TABLET / ORAL | 2021-01-07 | 4b0b4de00fa7… | ||
| 2022-03-09 01:35 UTC | 2022-03 | A214684-001 | LORATADINE | 10MG | TABLET / ORAL | 2021-01-07 | bb7c543d1eb4… | ||
| 2021-12-28 21:50 UTC | 2021-12 | A214684-001 | LORATADINE | 10MG | TABLET / ORAL | 2021-01-07 | 782e0a99824c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A214684-001 | LORATADINE | 10MG | TABLET / ORAL | 2021-01-07 | 87673890dc5c… | ||
| 2021-03-12 10:30 UTC | 2021-03 | A214684-001 | LORATADINE | 10MG | TABLET / ORAL | 2021-01-07 | 5aa47cf7b7d7… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A214684-001 | LORATADINE | 10MG | TABLET / ORAL | 2021-01-07 | 6a51e52b5d6a… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A214684-001 | LORATADINE | 10MG | TABLET / ORAL | 2021-01-07 | 1c564ffb4f44… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A214684-001 | LORATADINE | 10MG | TABLET / ORAL | 2021-01-07 | ea1830bbd6c7… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A214684-001 | LORATADINE | 10MG | TABLET / ORAL | 2021-01-07 | a72a2bbeb626… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A214684-001 | LORATADINE | 10MG | TABLET / ORAL | 2021-01-07 | 9b2671bbb829… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A214684-001 | LORATADINE | 10MG | TABLET / ORAL | 2021-01-07 | a67488948f0b… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A214684-001 | LORATADINE | 10MG | TABLET / ORAL | 2021-01-07 | 3f0d92c62455… | ||
| 2023-05-13 08:27 UTC | 2023-05 | A214684-001 | LORATADINE | 10MG | TABLET / ORAL | 2021-01-07 | 053a50430f4f… | ||
| 2023-01-26 05:58 UTC | 2023-01 | A214684-001 | LORATADINE | 10MG | TABLET / ORAL | 2021-01-07 | 3bdfa0b2c4d7… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A214684-001 | LORATADINE | 10MG | TABLET / ORAL | 2021-01-07 | 3a93d1ddd44b… | ||
| 2022-10-28 04:53 UTC | 2022-10 | A214684-001 | LORATADINE | 10MG | TABLET / ORAL | 2021-01-07 | f41ea6bd6efb… | ||
| 2022-09-29 23:25 UTC | 2022-09 | A214684-001 | LORATADINE | 10MG | TABLET / ORAL | 2021-01-07 | e64feba35796… | ||
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A214684-001 | LORATADINE | 10MG | TABLET / ORAL | 2021-01-07 | cb3db0bc1861… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A214684-001 | LORATADINE | 10MG | TABLET / ORAL | 2021-01-07 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Gencare-Allergy Relief Loratadine Tablets, 10 mg | LORATADINE | Pioneer Life Sciences, LLC | 647dc957-4aee-48f6-bb77-e82d3b380e80 | 2025-06-30 | Warnings | 72090-051-01 72090-051 72090005101 e45f0822-5a81-429b-9518-a9c423d6f9c3 647dc957-4aee-48f6-bb77-e82d3b380e80 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.